A Trial to Evaluate Efficacy and Safety of Maridebart Cafraglutide in Adults Living With Elevated Liver Fat and Obesity or Overweight

Clinical trial NCT07441252 · RECRUITING

Trial details

NCT number: NCT07441252
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Overweight or Obesity and Elevated Liver Fat

Start date: 2026-03-05
Primary completion: 2027-09-29
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.